Advertisement






Click here for more guidelines.
CME Topic Collections Past Issues Search Current Issue Home
     

J Am Coll Cardiol, 2005; 46:899-905, doi:10.1016/j.jacc.2005.05.052 (Published online 24 August 2005).
© 2005 by the American College of Cardiology Foundation
This Article
Right arrow Abstract Freely available
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (5)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Yoshida, J.
Right arrow Articles by Kohno, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Yoshida, J.
Right arrow Articles by Kohno, M.

Treatment of Ischemic Limbs Based on Local Recruitment of Vascular Endothelial Growth Factor-Producing Inflammatory Cells With Ultrasonic Microbubble Destruction

Junji Yoshida, MD, Koji Ohmori, MD, PhD*, Hiroto Takeuchi, MD, PhD, Kaori Shinomiya, MD, PhD, Tsunetatsu Namba, MD, PhD, Isao Kondo, MD, PhD, Hideyasu Kiyomoto, MD, PhD and Masakazu Kohno, MD, PhD

Second Department of Internal Medicine, Kagawa University School of Medicine, Kagawa, Japan



View larger version (98K):

[in a new window]
 
Figure 1 Representative images during treatment by ultrasound and microbubbles. Dense opacification of the short-axis image of the mouse hind limb was obtained on the first frame of the multi-frame trigger mode (left), which was reduced on the subsequent frames.

 


View larger version (99K):

[in a new window]
 
Figure 2 (A) Representative photomicrographs of CD45 immunostaining of treated muscles on day 3. Bars indicate 50 µm. (B) The count of leukocytes defined as CD45-positive cells. The CD45-positive cell count was significantly higher in the US/MB group than in the other groups after treatment. (n = 10 for baseline, three mice were used for each subsequent column.) *p < 0.001 vs. the other groups by analysis of variance with Student-Newman-Keuls post-hoc test. US/MB = treated with both ultrasound and microbubbles; US = treated with microbubbles only; MB = treated with microbubbles only.

 


View larger version (126K):

[in a new window]
 
Figure 3 Expression of vascular endothelial growth factor (VEGF) by leukocytes. Double immunofluorescence stain revealed that distribution of macrophages (F4/80-positive) (top) and that of T-lymphocytes (CD3-positive) (bottom) are both super-imposable onto the corresponding VEGF stain. Bars indicate 50 µm.

 


View larger version (52K):

[in a new window]
 
Figure 4 (A) Representative Western blot photographs showing gradual decrease of vascular endothelial growth factor (VEGF) in the control group and re-increase of VEGF expression by US/MB treatment. (B) Such an effect was seen only in the US/MB group. (n = 18 for baseline, n = 3 to 6 for each subsequent column.) *p < 0.01 vs. the other groups. Abbreviations as in Figure 2.

 


View larger version (96K):

[in a new window]
 
Figure 5 (A) Alkaline phosphatase stain showing a greater capillary density in US/MB than the other groups on day 21. Bars indicate 50 µm. (B) Such an effect was statistically significant on days 7 and 21. (n = 12 for baseline, three mice were used for each subsequent column.) *p < 0.001 vs. the other groups. Abbreviations as in Figure 2.

 


View larger version (74K):

[in a new window]
 
Figure 6 (A) Photographs showing greater vascularity of treated skeletal muscle in the US/MB group compared with the control group on day 21. Bars indicate 1 mm. (B) Vascularity quantified with the grid method was greater in the US/MB group than in the other groups on days 7 and 21. (n = 5 to 10 for each column.) *p < 0.001 vs. the other groups. Abbreviations as in Figure 2.

 


View larger version (33K):

[in a new window]
 
Figure 7 Augmented restoration of blood flow to the treated ischemic limbs in the US/MB group. (n = 12 for baseline, three mice were used for each subsequent column.) *p < 0.05 vs. MB. {dagger}p < 0.05 vs. the other groups. Abbreviations as in Figure 2.

 


View larger version (19K):

[in a new window]
 
Figure 8 Progressive prolongation of treadmill time in the US/MB group. (n = 6 to 12 for each group.) *p < 0.05 vs. the other groups. Abbreviations as in Figure 2.

 




 
  CME Topic Collections Past Issues Search Current Issue Home

Advertisement